I must agree very disappointing, should have sold when I knew they bought in @ 70cents, they will make up there losses in management fees, as they have a history of doing. Champee
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025